Insiders Are Scooping Up These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
Zenas BioPharma, Inc. (ZBIO)
Company Research
Source: Yahoo! Finance
Some rely on charts, others follow macro trends, while many stick with dividends or lean on analyst opinions. The challenge isn't finding ideas – it's figuring out which ones actually hold up when it matters. Easter Sale - 70% Off TipRanks Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks One approach that has consistently earned its place is tracking insider activity. Executives, board members, and senior leaders aren't just observing the business from the outside – they are the ones steering it, with a clear view of what's happening beneath the surface and what could lie ahead. That vantage point makes their trading activity hard to ignore. When insiders start putting serious money to work, it tends to reflect a level of conviction that goes beyond headlines or quarterly noise. And thanks to disclosure rules, those moves don't st
Show less
Read more
Impact Snapshot
Event Time:
ZBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBIO alerts
High impacting Zenas BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
ZBIO
News
- Zenas BioPharma's Key Milestones And Market Context: Holding Through The BLA [Seeking Alpha]Seeking Alpha
- Zenas BioPharma (ZBIO) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk [Yahoo! Finance]Yahoo! Finance
- Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 MillionGlobeNewswire
- Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common StockGlobeNewswire
ZBIO
Earnings
- 3/16/26 - Miss
ZBIO
Sec Filings
- 4/2/26 - Form SCHEDULE
- 4/2/26 - Form 4
- 4/1/26 - Form 4
- ZBIO's page on the SEC website